{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anticancer mechanisms", "antineoplastics discovery", "signaling pathways", "withaferin A", "withanolides"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "PMID": "38176694", "DateCompleted": {"Year": "2024", "Month": "02", "Day": "15"}, "DateRevised": {"Year": "2024", "Month": "02", "Day": "15"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1002/ptr.8090"], "ArticleDate": [{"Year": "2024", "Month": "01", "Day": "04"}], "Journal": {"ISSN": "1099-1573", "JournalIssue": {"Volume": "38", "Issue": "2", "PubDate": {"Year": "2024", "Month": "Feb"}}, "Title": "Phytotherapy research : PTR", "ISOAbbreviation": "Phytother Res"}, "ArticleTitle": "Withanolides: Promising candidates for cancer therapy.", "Pagination": {"StartPage": "1104", "EndPage": "1158", "MedlinePgn": "1104-1158"}, "Abstract": {"AbstractText": ["Natural products have played a significant role throughout history in the prevention and treatment of numerous diseases, particularly cancers. As a natural product primarily derived from various medicinal plants in the Withania genus, withanolides have been shown in several studies to exhibit potential activities in cancer treatment. Consequently, understanding the molecular mechanism of withanolides could herald the discovery of new anticancer agents. Withanolides have been studied widely, especially in the last 20\u2009years, and attracted the attention of numerous researchers. Currently, over 1200 withanolides have been classified, with approximately a quarter of them having been reported in the literature to be able to modulate the survival and death of cancer cells through multiple avenues. To what extent, though, has the anticancer effects of these compounds been studied? How far are they from being developed into clinical drugs? What are their potential, characteristic features, and challenges? In this review, we elaborate on the current knowledge of natural compounds belonging to this class and provide an overview of their natural sources, anticancer activity, mechanism of action, molecular targets, and implications for anticancer drug research. In addition, direct targets and clinical research to guide the design and implementation of future preclinical and clinical studies to accelerate the application of withanolides have been highlighted."], "CopyrightInformation": "\u00a9 2024 John Wiley & Sons Ltd."}, "AuthorList": [{"Identifier": ["0000-0002-0691-7448"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China."}], "LastName": "Zhang", "ForeName": "Qiang", "Initials": "Q"}, {"Identifier": ["0009-0008-6065-1573"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China."}], "LastName": "Yuan", "ForeName": "YongKang", "Initials": "Y"}, {"Identifier": ["0000-0001-9164-882X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China."}, {"Identifier": [], "Affiliation": "Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China."}], "LastName": "Cao", "ForeName": "Shijie", "Initials": "S"}, {"Identifier": ["0000-0002-4953-0462"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "School of Medical Technology, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China."}], "LastName": "Kang", "ForeName": "Ning", "Initials": "N"}, {"Identifier": ["0000-0001-5505-8670"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China."}, {"Identifier": [], "Affiliation": "Tianjin Key Laboratory of Therapeutic Substance of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China."}, {"Identifier": [], "Affiliation": "School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, People's Republic of China."}], "LastName": "Qiu", "ForeName": "Feng", "Initials": "F"}], "GrantList": [{"GrantID": "82104461", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "21472138", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "81873079", "Agency": "National Natural Science Foundation of China", "Country": ""}, {"GrantID": "82274221", "Agency": "National Natural Science Foundation of China", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Phytother Res", "NlmUniqueID": "8904486", "ISSNLinking": "0951-418X"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Withanolides"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Withanolides"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Withania"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Aaes, T. L., Kaczmarek, A., Delvaeye, T., De Craene, B., De Koker, S., Heyndrickx, L., Delrue, I., Taminau, J., Wiernicki, B., De Groote, P., Garg, A. D., Leybaert, L., Grooten, J., Bertrand, M. J. M., Agostinis, P., Berx, G., Declercq, W., Vandenabeele, P., & Krysko, D. V. (2016). Vaccination with Necroptotic cancer cells induces efficient anti-tumor immunity. Cell Reports, 15, 274-287."}, {"Citation": "Abeesh, P., Vishnu, W. K., & Guruvayoorappan, C. (2021). Preparation and characterization of withaferin A loaded pegylated nanoliposomal formulation with high loading efficacy: In vitro and in vivo anti-tumour study. Mater Sci Eng C Mater Biol Appl, 128, 112335 Netherlands."}, {"Citation": "Abraham, J., Salama, N. N., & Azab, A. K. (2015). The role of P-glycoprotein in drug resistance in multiple myeloma. Leukemia & Lymphoma, 56, 26-33."}, {"Citation": "Abreu, A. S., Castanheira, E. M., Queiroz, M.-J. R., Ferreira, P. M., Vale-Silva, L. A., & Pinto, E. (2011). Nanoliposomes for encapsulation and delivery of the potential antitumoral methyl 6-methoxy-3-(4-methoxyphenyl)-1H-indole-2-carboxylate. Nanoscale Research Letters, 6, 482."}, {"Citation": "Agarwalla, P., Mukherjee, S., Sreedhar, B., & Banerjee, R. (2016). Glucocorticoid receptor-mediated delivery of nano gold-withaferin conjugates for reversal of epithelial-to-mesenchymal transition and tumor regression. Nanomed, 11, 2529-2546."}, {"Citation": "Akhtar, N., Baig, M. W., Haq, I.-U., Rajeeve, V., & Cutillas, P. R. (2020). Withanolide metabolites inhibit PI3K/AKT and MAPK pro-survival pathways and induce apoptosis in acute myeloid Leukemia cells. Biomedicine, 8, 333."}, {"Citation": "Aliebrahimi, S., Kouhsari, S. M., Arab, S. S., Shadboorestan, A., & Ostad, S. N. (2018). Phytochemicals, withaferin A and carnosol, overcome pancreatic cancer stem cells as c-met inhibitors. Biomed Pharmacother Biomedecine Pharmacother, 106, 1527-1536. France."}, {"Citation": "Amelio, I., Cutruzzol\u00e1, F., Antonov, A., Agostini, M., & Melino, G. (2014). Serine and glycine metabolism in cancer. Trends in Biochemical Sciences, 39, 191-198."}, {"Citation": "Antony, M. L., Lee, J., Hahm, E.-R., Kim, S.-H., Marcus, A. I., Kumari, V., Ji, X., Yang, Z., Vowell, C. L., Wipf, P., Uechi, G. T., Yates, N. A., Romero, G., Sarkar, S. N., & Singh, S. V. (2014). Growth arrest by the antitumor steroidal lactone Withaferin A in human breast cancer cells is associated with Down-regulation and covalent binding at cysteine 303 of \u03b2-tubulin. The Journal of Biological Chemistry, 289, 1852-1865."}, {"Citation": "Aqil, F., Jeyabalan, J., Kausar, H., Bansal, S. S., Sharma, R. J., Singh, I. P., Vadhanam, M. V., & Gupta, R. C. (2012). Multi-layer polymeric implants for sustained release of chemopreventives. Cancer Letters, 326, 33-40."}, {"Citation": "Arai, M. A., Uchida, K., Sadhu, S. K., Ahmed, F., & Ishibashi, M. (2014). Physalin H from Solanum nigrum as an Hh signaling inhibitor blocks GLI1-DNA-complex formation. Beilstein Journal of Organic Chemistry, 10, 134-140."}, {"Citation": "Ausseil, F., Samson, A., Aussagues, Y., Vandenberghe, I., Creancier, L., Pouny, I., Kruczynski, A., Massiot, G., & Bailly, C. (2007). High-throughput bioluminescence screening of ubiquitin-proteasome pathway inhibitors from chemical and natural sources. SLAS Discov, 12, 106-116."}, {"Citation": "Bahrami, B., Hojjat-Farsangi, M., Mohammadi, H., Anvari, E., Ghalamfarsa, G., Yousefi, M., & Jadidi-Niaragh, F. (2017). Nanoparticles and targeted drug delivery in cancer therapy. Immunology Letters, 190, 64-83."}, {"Citation": "Baig, M. W., Nasir, B., Waseem, D., Majid, M., Khan, M. Z. I., & Haq, I. (2020). Withametelin: A biologically active withanolide in cancer, inflammation, pain and depression. Saudi Pharm J, 28, 1526-1537."}, {"Citation": "Bargagna-Mohan, P., Hamza, A., Kim, Y., Khuan (Abby) Ho, Y., Mor-Vaknin, N., Wendschlag, N., Liu, J., Evans, R. M., Markovitz, D. M., Zhan, C.-G., Kim, K. B., & Mohan, R. (2007). The tumor inhibitor and antiangiogenic agent Withaferin A targets the intermediate filament protein Vimentin. Chemistry & Biology, 14, 623-634."}, {"Citation": "Barolo, S. (2006). Transgenic Wnt/TCF pathway reporters: All you need is Lef? Oncogene, 25, 7505-7511."}, {"Citation": "Batlle, E., & Clevers, H. (2017). Cancer stem cells revisited. Nature Medicine, 23, 1124-1134."}, {"Citation": "Bhargava, P., Malik, V., Liu, Y., Ryu, J., Kaul, S. C., Sundar, D., & Wadhwa, R. (2019). Molecular insights into Withaferin-A-induced senescence: Bioinformatics and experimental evidence to the role of NF\u03baB and CARF. J Gerontol A Biol Sci Med Sci, 74, 183-191. United States."}, {"Citation": "Bianchini, G., Balko, J. M., Mayer, I. A., Sanders, M. E., & Gianni, L. (2016). Triple-negative breast cancer: Challenges and opportunities of a heterogeneous disease. Nature Reviews. Clinical Oncology, 13, 674-690."}, {"Citation": "Biswal, B. M., Sulaiman, A. M., Ismail, H. C., Zakaria, H., Jalil Abdul, M. I., & Muhammad, K. I. (2012). AOS14 phase II clinical study of combination chemotherapy with herb Withania somnifera (ashwagandha) in breast cancer. European Journal of Cancer, 48, S8-S9."}, {"Citation": "Biswal, B. M., Sulaiman, S. A., Ismail, H. C., Zakaria, H., & Musa, K. I. (2013). Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients. Integrative Cancer Therapies, 12, 312-322."}, {"Citation": "Boutros, T., Chevet, E., & Metrakos, P. (2008). Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: Roles in cell growth, death, and cancer. Pharmacological Reviews, 60, 261-310."}, {"Citation": "Bugter, J. M., Fenderico, N., & Maurice, M. M. (2021). Mutations and mechanisms of WNT pathway tumour suppressors in cancer. Nature Reviews. Cancer, 21, 5-21."}, {"Citation": "Cabasag, C. J., Fagan, P. J., Ferlay, J., Vignat, J., Laversanne, M., Liu, L., van der Aa, M. A., Bray, F., & Soerjomataram, I. (2022). Ovarian cancer today and tomorrow: A global assessment by world region and human development index using GLOBOCAN 2020. International Journal of Cancer, 151, 1535-1541."}, {"Citation": "Cao, C., Zhu, L., Chen, Y., Wang, C.-H., ShenTu, J., & Zheng, Y.-L. (2019). Physalin B induces G2/M cell cycle arrest and apoptosis in A549 human non-small-cell lung cancer cells by altering mitochondrial function. Anti-Cancer Drugs, 30, 128-137."}, {"Citation": "Carneiro, B. A., & El-Deiry, W. S. (2020). Targeting apoptosis in cancer therapy. Nature Reviews. Clinical Oncology, 17, 395-417."}, {"Citation": "Caruso Bavisotto, C., Marino Gammazza, A., Campanella, C., Bucchieri, F., & Cappello, F. (2022). Extracellular heat shock proteins in cancer: From early diagnosis to new therapeutic approach. Seminars in Cancer Biology, 86, 36-45."}, {"Citation": "Chandan, M., Dutta, A., Mallick, A., Chandra, S., Misra, L., Sangwan, R. S., & Chitra, M. (2008). Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Apoptosis, 13, 1450-1464."}, {"Citation": "Chandran, U., & Patwardhan, B. (2017). Network ethnopharmacological evaluation of the immunomodulatory activity of Withania somnifera. Journal of Ethnopharmacology, 197, 250-256."}, {"Citation": "Chandrasekaran, B., Pal, D., Kolluru, V., Tyagi, A., Baby, B., Dahiya, N. R., Youssef, K., Alatassi, H., Ankem, M. K., Sharma, A. K., & Damodaran, C. (2018). The chemopreventive effect of withaferin A on spontaneous and inflammation-associated colon carcinogenesis models. Carcinogenesis, 39, 1537-1547."}, {"Citation": "Chang, H.-C., Chang, F.-R., Wang, Y.-C., Pan, M.-R., Hung, W.-C., & Wu, Y.-C. (2007). A bioactive withanolide Tubocapsanolide A inhibits proliferation of human lung cancer cells via repressing Skp2 expression. Molecular Cancer Therapeutics, 6, 1572-1578."}, {"Citation": "Chaudhary, A., Kalra, R. S., Malik, V., Katiyar, S. P., Sundar, D., Kaul, S. C., & Wadhwa, R. (2019). 2, 3-Dihydro-3\u03b2-methoxy Withaferin-A lacks anti-metastasis potency: Bioinformatics and experimental evidences. Scientific Reports, 9, 17344."}, {"Citation": "Chen, C., Zhu, T., Liu, X., Zhu, D., Zhang, Y., Wu, S., Han, C., Zhang, H., Luo, J., & Kong, L. (2022). Identification of a novel PHGDH covalent inhibitor by chemical proteomics and phenotypic profiling. Acta Pharmaceutica Sinica B, 12, 246-261."}, {"Citation": "Chen, L., Xia, G., Qiu, F., Wu, C., Denmon, A. P., & Zi, X. (2016). Physapubescin selectively induces apoptosis in VHL-null renal cell carcinoma cells through down-regulation of HIF-2\u03b1 and inhibits tumor growth. Sci Rep, 6, 32582 England."}, {"Citation": "Chen, L.-X., He, H., & Qiu, F. (2011). Natural withanolides: An overview. Nat Prod Rep, 28, 705-740. England."}, {"Citation": "Chen, L.-X., Xia, G.-Y., He, H., Huang, J., Qiu, F., & Zi, X.-L. (2016). New withanolides with TRAIL-sensitizing effect from Physalis pubescens L. RSC Adv, 6, 52925-52936. England."}, {"Citation": "Chen, W.-Y., Chang, F.-R., Huang, Z.-Y., Chen, J.-H., Wu, Y.-C., & Wu, C.-C. (2008). Tubocapsenolide A, a novel withanolide, inhibits proliferation and induces apoptosis in MDA-MB-231 cells by thiol oxidation of heat shock proteins. The Journal of Biological Chemistry, 283, 17184-17193."}, {"Citation": "Chen, X., Kang, R., Kroemer, G., & Tang, D. (2021). Broadening horizons: The role of ferroptosis in cancer. Nature Reviews. Clinical Oncology, 18, 280-296."}, {"Citation": "Cheng, L., Wu, C.-R., Zhu, L.-H., Li, H., & Chen, L.-X. (2017). Physapubescin, a natural withanolide as a kidney-type glutaminase (KGA) inhibitor. Bioorganic & Medicinal Chemistry Letters, 27, 1243-1246."}, {"Citation": "Chiu, C.-C., Haung, J.-W., Chang, F.-R., Huang, K.-J., Huang, H.-M., Huang, H.-W., Chou, C.-K., Wu, Y.-C., & Chang, H.-W. (2013). Golden berry-derived 4\u03b2-hydroxywithanolide E for selectively killing Oral cancer cells by generating ROS, DNA damage, and apoptotic pathways. PLoS One, 8, e64739."}, {"Citation": "Choi, B. Y., & Kim, B.-W. (2015). Withaferin-A inhibits colon cancer cell growth by blocking STAT3 transcriptional activity. J Cancer Prev, 20, 185-192."}, {"Citation": "Choi, J. K., Murillo, G., Su, B.-N., Pezzuto, J. M., Kinghorn, A. D., & Mehta, R. G. (2006). Ixocarpalactone A isolated from the Mexican tomatillo shows potent antiproliferative and apoptotic activity in colon cancer cells: Tomatillo and colon carcinogenesis. The FEBS Journal, 273, 5714-5723."}, {"Citation": "Choi, M. J., Park, E. J., Min, K. J., Park, J.-W., & Kwon, T. K. (2011). Endoplasmic reticulum stress mediates withaferin A-induced apoptosis in human renal carcinoma cells. Toxicology in Vitro, 25, 692-698."}, {"Citation": "Clark, A. G., & Vignjevic, D. M. (2015). Modes of cancer cell invasion and the role of the microenvironment. Current Opinion in Cell Biology, 36, 13-22."}, {"Citation": "Clark, P. E. (2009). The role of VHL in clear-cell renal cell carcinoma and its relation to targeted therapy. Kidney International, 76, 939-945."}, {"Citation": "Cohen, S. M., Mukerji, R., Timmermann, B. N., Samadi, A. K., & Cohen, M. S. (2012). A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers. American Journal of Surgery, 204, 895-901."}, {"Citation": "Dai, C., Shen, L., Jin, W., Lv, B., Liu, P., Wang, X., Yin, Y., Fu, Y., Liang, L., Ma, Z., Zhang, X., Wang, Y., Xu, D., & Chen, Z. (2020). Physapubescin B enhances the sensitivity of gastric cancer cells to trametinib by inhibiting the STAT3 signaling pathway. Toxicology and Applied Pharmacology, 408, 115273, United States."}, {"Citation": "Dai, T., Jiang, W., Guo, Z., Wang, Z., Huang, M., Zhong, G., Liang, C., Pei, X., & Dai, R. (2019). Studies on oral bioavailability and first-pass metabolism of withaferin A in rats using LC-MS/MS and Q-TRAP. Biomed Chromatogr, 33, 33."}, {"Citation": "Damu, A. G., Kuo, P.-C., Su, C.-R., Kuo, T.-H., Chen, T.-H., Bastow, K. F., Lee, K.-H., & Wu, T.-S. (2007). Isolation, structures, and structure\u2212cytotoxic activity relationships of Withanolides and Physalins from Physalis angulata. Journal of Natural Products, 70, 1146-1152."}, {"Citation": "Dang, L., Yen, K., & Attar, E. C. (2016). IDH mutations in cancer and progress toward development of targeted therapeutics. Annals of Oncology, 27, 599-608."}, {"Citation": "Dang, Y., & Guan, J. (2020). Nanoparticle-based drug delivery systems for cancer therapy. Smart Materials in Medicine, 1, 10-19."}, {"Citation": "Das, T., Roy, K. S., Chakrabarti, T., Mukhopadhyay, S., & Roychoudhury, S. (2014). Withaferin A modulates the spindle assembly checkpoint by degradation of Mad2-Cdc20 complex in colorectal cancer cell lines. Biochemical Pharmacology, 91, 31-39."}, {"Citation": "Das, T. P., Suman, S., Alatassi, H., Ankem, M. K., & Damodaran, C. (2016). Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer. Cell Death & Disease, 7, e2111."}, {"Citation": "Davis, L., & Kuttan, G. (2002a). Effect of Withania somnifera on cell mediated immune responses in mice. J Exp Clin Cancer Res CR, 21, 585-590."}, {"Citation": "Davis, L., & Kuttan, G. (2002b). Effect of Withania somnifera on CTL activity. J Exp Clin Cancer Res CR, 21, 115-118."}, {"Citation": "De Palma, M., & Lewis, C. E. (2013). Macrophage regulation of tumor responses to anticancer therapies. Cancer Cell, 23, 277-286."}, {"Citation": "Dean, M., Fojo, T., & Bates, S. (2005). Tumour stem cells and drug resistance. Nature reviews. Cancer, 5, 275-284."}, {"Citation": "Dekker, E., Tanis, P. J., Vleugels, J. L. A., Kasi, P. M., & Wallace, M. B. (2019). Colorectal cancer. Lancet Lond Engl, 394, 1467-1480."}, {"Citation": "Denisenko, T. V., Sorokina, I. V., Gogvadze, V., & Zhivotovsky, B. (2016). Mitotic catastrophe and cancer drug resistance: A link that must to be broken. Drug Resist Updat Rev Comment Antimicrob Anticancer Chemother, 24, 1-12."}, {"Citation": "Devkar, S., Kandhare, A., Sloley, B., Jagtap, S., Lin, J., Tam, Y., Katyare, S., Bodhankar, S., & Hegde, M. (2015). Evaluation of the bioavailability of major withanolides of Withania somnifera using an in vitro absorption model system. Journal of Advanced Pharmaceutical Technology & Research, 6, 159."}, {"Citation": "Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007). MAP kinase signalling pathways in cancer. Oncogene, 26, 3279-3290."}, {"Citation": "Ding, W., Hu, Z., Zhang, Z., Ma, Q., Tang, H., & Ma, Z. (2015). Physapubescin B exhibits potent activity against human prostate cancer in vitro and in vivo. Journal of Agricultural and Food Chemistry, 63, 9504-9512."}, {"Citation": "Du, Z., Shen, Y., Yang, W., Mecklenbrauker, I., Neel, B. G., & Ivashkiv, L. B. (2005). Inhibition of IFN-\u03b1 signaling by a PKC- and protein tyrosine phosphatase SHP-2-dependent pathway. Proceedings of the National Academy of Sciences, 102, 10267-10272."}, {"Citation": "Eluard, B., Thieblemont, C., & Baud, V. (2020). NF-\u03baB in the new era of cancer therapy. Trends Cancer, 6, 677-687."}, {"Citation": "Falsey, R. R., Marron, M. T., Gunaherath, G. M. K. B., Shirahatti, N., Mahadevan, D., Gunatilaka, A. A. L., & Whitesell, L. (2006). Actin microfilament aggregation induced by withaferin A is mediated by annexin II. Nature Chemical Biology, 2, 33-38."}, {"Citation": "Fan, Y., Mao, Y., Cao, S., Xia, G., Zhang, Q., Zhang, H., Qiu, F., & Kang, N. (2018). S5, a Withanolide isolated from Physalis pubescens L., induces G2/M cell cycle arrest via the EGFR/P38 pathway in human melanoma A375 cells. Mol Basel Switz, 23, 3175."}, {"Citation": "Ferreira, A., & Aster, J. C. (2022). Notch signaling in cancer: Complexity and challenges on the path to clinical translation. Seminars in Cancer Biology, 85, 95-106."}, {"Citation": "Fong, M. Y., Jin, S., Rane, M., Singh, R. K., Gupta, R., & Kakar, S. S. (2012). Withaferin A synergizes the therapeutic effect of doxorubicin through ROS-mediated autophagy in ovarian cancer. PLoS One, 7, 16."}, {"Citation": "Friedl, P., & Mayor, R. (2017). Tuning collective cell migration by cell-cell junction regulation. Cold Spring Harbor Perspectives in Biology, 9, a029199."}, {"Citation": "Galluzzi, L., Humeau, J., Buqu\u00e9, A., Zitvogel, L., & Kroemer, G. (2020). Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nature Reviews. Clinical Oncology, 17, 725-741."}, {"Citation": "Gao, R., Shah, N., Lee, J.-S., Katiyar, S. P., Li, L., Oh, E., Sundar, D., Yun, C.-O., Wadhwa, R., & Kaul, S. C. (2014). Withanone-rich combination of Ashwagandha Withanolides restricts metastasis and angiogenesis through hnRNP-K. Molecular Cancer Therapeutics, 13, 2930-2940."}, {"Citation": "Garg, S., Huifu, H., Kumari, A., Sundar, D., Kaul, S. C., & Wadhwa, R. (2020). Induction of senescence in cancer cells by a novel combination of Cucurbitacin B and Withanone: Molecular mechanism and therapeutic potential. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 75, 1031-1041. United States."}, {"Citation": "Gavas, S., Quazi, S., & Karpi\u0144ski, T. M. (2021). Nanoparticles for cancer therapy: Current Progress and challenges. Nanoscale Research Letters, 16, 173."}, {"Citation": "Ghosh, K., De, S., Das, S., Mukherjee, S., & Sengupta Bandyopadhyay, S. (2016). Withaferin A induces ROS-mediated Paraptosis in human breast cancer cell-lines MCF-7 and MDA-MB-231. PLoS One, 11, e0168488."}, {"Citation": "Ghosh, K., De, S., Mukherjee, S., Das, S., Ghosh, A. N., & Sengupta, S. B. (2017). Withaferin A induced impaired autophagy and unfolded protein response in human breast cancer cell-lines MCF-7 and MDA-MB-231. Toxicol Vitro Int J Publ Assoc BIBRA, 44, 330-338."}, {"Citation": "Gilbertson, R. J. (2011). Mapping cancer origins. Cell, 145, 25-29."}, {"Citation": "Gottesman, M. M., & Pastan, I. H. (2015). The role of multidrug resistance efflux pumps in cancer: Revisiting a JNCI publication exploring expression of the MDR1 (P-glycoprotein) gene. Journal of the National Cancer Institute, 107, djv222."}, {"Citation": "Grogan, P. T., Sarkaria, J. N., Timmermann, B. N., & Cohen, M. S. (2014). Oxidative cytotoxic agent withaferin A resensitizes temozolomide-resistant glioblastomas via MGMT depletion and induces apoptosis through Akt/mTOR pathway inhibitory modulation. Investigational New Drugs, 14, 604-617."}, {"Citation": "Grogan, P. T., Sleder, K. D., Samadi, A. K., Zhang, H., Timmermann, B. N., & Cohen, M. S. (2013). Cytotoxicity of withaferin A in glioblastomas involves induction of an oxidative stress-mediated heat shock response while altering Akt/mTOR and MAPK signaling pathways. Investigational New Drugs, 31, 545-557."}, {"Citation": "Grossman, E. A., Ward, C. C., Spradlin, J. N., Bateman, L. A., Huffman, T. R., Miyamoto, D. K., Kleinman, J. I., & Nomura, D. K. (2017). Covalent ligand discovery against Druggable hotspots targeted by anti-cancer natural products. Cell Chemical Biology, 24, 1368-1376.e4."}, {"Citation": "Gu, M., Yu, Y., Gunatilaka, A. A. L., Li, D., & Sun, D. (2014). Structure-activity relationship (SAR) of withanolides to inhibit Hsp90 for its activity in pancreatic cancer cells. Investigational New Drugs, 7, 68-74."}, {"Citation": "Gupta, R. C., Bansal, S. S., Aqil, F., Jeyabalan, J., Cao, P., Kausar, H., Russell, G. K., Munagala, R., Ravoori, S., & Vadhanam, M. V. (2012). Controlled-release systemic delivery-a new concept in cancer chemoprevention. Carcinogenesis, 33, 1608-1615."}, {"Citation": "Hahm, E.-R., Kim, S.-H., Singh, K. B., & Singh, S. V. (2021). RNA-seq reveals novel cancer-selective and disease subtype-independent mechanistic targets of withaferin A in human breast cancer cells. Molecular Carcinogenesis, 60, 3-14."}, {"Citation": "Hahm, E.-R., Lee, J., Abella, T., & Singh, S. V. (2019). Withaferin A inhibits expression of ataxia telangiectasia and Rad3-related kinase and enhances sensitivity of human breast cancer cells to cisplatin. Molecular Carcinogenesis, 58, 2139-2148."}, {"Citation": "Hahm, E.-R., Lee, J., Huang, Y., & Singh, S. V. (2011). Withaferin a suppresses estrogen receptor-\u03b1 expression in human breast cancer cells. Molecular Carcinogenesis, 50, 614-624."}, {"Citation": "Hahm, E.-R., Lee, J., Kim, S.-H., Sehrawat, A., Arlotti, J. A., Shiva, S. S., Bhargava, R., & Singh, S. V. (2013). Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model. Journal of the National Cancer Institute, 105, 1111-1122."}, {"Citation": "Hahm, E.-R., Moura, M. B., Kelley, E. E., Van Houten, B., Shiva, S., & Singh, S. V. (2011). Withaferin A-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species. PLoS One, 6, e23354."}, {"Citation": "Hahm, E.-R., & Singh, S. V. (2013). Withaferin A-induced apoptosis in human breast cancer cells is associated with suppression of inhibitor of apoptosis family protein expression. Cancer Letters, 334, 101-108."}, {"Citation": "Hahm, E.-R., & Singh, S. V. (2020). Cytoprotective autophagy induction by withaferin A in prostate cancer cells involves GABARAPL1. Molecular Carcinogenesis, 59, 1105-1115."}, {"Citation": "Haider, T., Pandey, V., Banjare, N., Gupta, P. N., & Soni, V. (2020). Drug resistance in cancer: Mechanisms and tackling strategies. Pharmacol Rep PR, 72, 1125-1151."}, {"Citation": "Han, H., Qiu, L., Wang, X., Qiu, F., Wong, Y., & Yao, X. (2011). Physalins A and B inhibit androgen-independent prostate cancer cell growth through activation of cell apoptosis and downregulation of androgen receptor expression. Biological & Pharmaceutical Bulletin, 34, 1584-1588."}, {"Citation": "Hanahan, D. (2022). Hallmarks of cancer: New dimensions. Cancer Discovery, 12, 31-46."}, {"Citation": "Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144, 646-674."}, {"Citation": "Hassannia, B., Wiernicki, B., Ingold, I., Qu, F., Van Herck, S., Tyurina, Y. Y., Bay\u0131r, H., Abhari, B. A., Angeli, J. P. F., Choi, S. M., Meul, E., Heyninck, K., Declerck, K., Chirumamilla, C. S., Lahtela-Kakkonen, M., Van Camp, G., Krysko, D. V., Ekert, P. G., Fulda, S., \u2026 Vanden Berghe, T. (2018). Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma. The Journal of Clinical Investigation, 128, 3341-3355."}, {"Citation": "He, H., Feng, Y.-S., Zang, L.-H., Liu, W.-W., Ding, L.-Q., Chen, L.-X., Kang, N., Hayashi, T., Tashiro, S., Onodera, S., Qiu, F., & Ikejima, T. (2014). Nitric oxide induces apoptosis and autophagy; autophagy down-regulates NO synthesis in physalin A-treated A375-S2 human melanoma cells. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc, 71, 128-135."}, {"Citation": "He, H., Zang, L.-H., Feng, Y.-S., Chen, L.-X., Kang, N., Tashiro, S., Onodera, S., Qiu, F., & Ikejima, T. (2013). Physalin A induces apoptosis via p53-Noxa-mediated ROS generation, and autophagy plays a protective role against apoptosis through p38-NF-\u03baB survival pathway in A375-S2 cells. Journal of Ethnopharmacology, 148, 544-555."}, {"Citation": "He, H., Zang, L.-H., Feng, Y.-S., Wang, J., Liu, W.-W., Chen, L.-X., Kang, N., Tashiro, S., Onodera, S., Qiu, F., & Ikejima, T. (2013). Physalin A induces apoptotic cell death and protective autophagy in HT1080 human fibrosarcoma cells. J Nat Prod, 76, 880-888."}, {"Citation": "He, Y., Sun, M. M., Zhang, G. G., Yang, J., Chen, K. S., Xu, W. W., & Li, B. (2021). Targeting PI3K/Akt signal transduction for cancer therapy. Signal Transduction and Targeted Therapy, 6, 425."}, {"Citation": "Henrich, C. J., Brooks, A. D., Erickson, K. L., Thomas, C. L., Bokesch, H. R., Tewary, P., Thompson, C. R., Pompei, R. J., Gustafson, K. R., McMahon, J. B., & Sayers, T. J. (2015). Withanolide E sensitizes renal carcinoma cells to TRAIL-induced apoptosis by increasing cFLIP degradation. Cell Death & Disease, 6, e1666."}, {"Citation": "Hensley, C. T., Wasti, A. T., & DeBerardinis, R. J. (2013). Glutamine and cancer: Cell biology, physiology, and clinical opportunities. The Journal of Clinical Investigation, 123, 3678-3684."}, {"Citation": "Herranz, N., & Gil, J. (2018). Mechanisms and functions of cellular senescence. The Journal of Clinical Investigation, 128, 1238-1246."}, {"Citation": "Heyninck, K., Lahtela-Kakkonen, M., Van der Veken, P., Haegeman, G., & Vanden Berghe, W. (2014). Withaferin A inhibits NF-kappaB activation by targeting cysteine 179 in IKK\u03b2. Biochemical Pharmacology, 91, 501-509."}, {"Citation": "Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013). Cancer drug resistance: An evolving paradigm. Nature Reviews. Cancer, 13, 714-726."}, {"Citation": "Hoxhaj, G., & Manning, B. D. (2020). The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. Nature Reviews. Cancer, 20, 74-88."}, {"Citation": "Hsieh, K.-Y., Tsai, J.-Y., Lin, Y.-H., Chang, F.-R., Wang, H.-C., & Wu, C.-C. (2021). Golden berry 4\u03b2-hydroxywithanolide E prevents tumor necrosis factor \u03b1-induced procoagulant activity with enhanced cytotoxicity against human lung cancer cells. Scientific Reports, 11, 4610."}, {"Citation": "Hsu, C.-C., Wu, Y.-C., Farh, L., Du, Y.-C., Tseng, W.-K., Wu, C.-C., & Chang, F.-R. (2012). Physalin B from Physalis angulata triggers the NOXA-related apoptosis pathway of human melanoma A375 cells. Food Chem Toxicol Int J Publ Br Ind Biol Res Assoc, 50, 619-624."}, {"Citation": "Hsu, J. H.-M., Chang, P. M.-H., Cheng, T.-S., Kuo, Y.-L., Wu, A. T.-H., Tran, T.-H., Yang, Y.-H., Chen, J.-M., Tsai, Y.-C., Chu, Y.-S., Huang, T.-H., Huang, C.-Y. F., & Lai, J.-M. (2019). Identification of Withaferin A as a potential candidate for anti-cancer therapy in non-small cell lung cancer. Cancers, 11, 1003."}, {"Citation": "Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021). The JAK/STAT signaling pathway: From bench to clinic. Signal Transduction and Targeted Therapy, 6, 402."}, {"Citation": "Huang, F., & Chen, Y.-G. (2012). Regulation of TGF-\u03b2 receptor activity. Cell & Bioscience, 2, 9."}, {"Citation": "Ichikawa, H., Takada, Y., Shishodia, S., Jayaprakasam, B., Nair, M. G., & Aggarwal, B. B. (2006). Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-\u03baB (NF-\u03baB) activation and NF-\u03baB-regulated gene expression. Molecular Cancer Therapeutics, 5, 1434-1445."}, {"Citation": "Issa, M. E., Wijeratne, E. M. K., Gunatilaka, A. A. L., & Cuendet, M. (2017). Withanolide D exhibits similar cytostatic effect in drug-resistant and drug-sensitive multiple myeloma cells. Frontiers in Pharmacology, 8, 610."}, {"Citation": "Jager, M. J., Shields, C. L., Cebulla, C. M., Abdel-Rahman, M. H., Grossniklaus, H. E., Stern, M.-H., Carvajal, R. D., Belfort, R. N., Jia, R., Shields, J. A., & Damato, B. E. (2020). Uveal melanoma. Nat Rev Dis Primer, 6, 24."}, {"Citation": "Jan, Y.-H., Lai, T.-C., Yang, C.-J., Lin, Y.-F., Huang, M.-S., & Hsiao, M. (2019). Adenylate kinase 4 modulates oxidative stress and stabilizes HIF-1\u03b1 to drive lung adenocarcinoma metastasis. J Hematol OncolJ Hematol Oncol, 12, 12."}, {"Citation": "Janes, S. M., Alrifai, D., & Fennell, D. A. (2021). Perspectives on the treatment of malignant pleural mesothelioma. The New England Journal of Medicine, 385, 1207-1218."}, {"Citation": "Jung, Y. Y., Um, J.-Y., Chinnathambi, A., Govindasamy, C., Narula, A. S., Namjoshi, O. A., Blough, B. E., Sethi, G., & Ahn, K. S. (2022). Withanolide modulates the potential crosstalk between apoptosis and autophagy in different colorectal cancer cell lines. European Journal of Pharmacology, 928, 175113."}, {"Citation": "Kaileh, M., Vanden Berghe, W., Heyerick, A., Horion, J., Piette, J., Libert, C., De Keukeleire, D., Essawi, T., & Haegeman, G. (2007). Withaferin A strongly elicits I\u03baB kinase \u03b2 hyperphosphorylation concomitant with potent inhibition of its kinase activity. The Journal of Biological Chemistry, 282, 4253-4264."}, {"Citation": "Kakar, S. S., Jala, V. R., & Fong, M. Y. (2012). Synergistic cytotoxic action of cisplatin and withaferin A on ovarian cancer cell lines. Biochemical and Biophysical Research Communications, 423, 819-825."}, {"Citation": "Kakar, S. S., Ratajczak, M. Z., Powell, K. S., Moghadamfalahi, M., Miller, D. M., Batra, S. K., & Singh, S. K. (2014). Withaferin A alone and in combination with cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells. PLoS One, 9, e107596."}, {"Citation": "Kalthur, G., & Pathirissery, U. D. (2010). Enhancement of the response of B16F1 melanoma to fractionated radiotherapy and prolongation of survival by Withaferin A and/or hyperthermia. Integrative Cancer Therapies, 9, 370-377."}, {"Citation": "Kim, E. K., & Choi, E.-J. (2010). Pathological roles of MAPK signaling pathways in human diseases. Biochimica et Biophysica Acta, 1802, 396-405."}, {"Citation": "Kim, S.-H., Hahm, E.-R., Arlotti, J. A., Samanta, S. K., Moura, M. B., Thorne, S. H., Shuai, Y., Anderson, C. J., White, A. G., Lokshin, A., Lee, J., & Singh, S. V. (2016). Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown. Breast Cancer Research and Treatment, 157, 41-54."}, {"Citation": "Kim, S.-H., Hahm, E.-R., Singh, K. B., Shiva, S., Stewart-Ornstein, J., & Singh, S. V. (2020). RNA-seq reveals novel mechanistic targets of withaferin A in prostate cancer cells. Carcinogenesis, 41, 778-789."}, {"Citation": "Ko, Y.-C., Choi, H. S., Liu, R., & Lee, D.-S. (2021). Physalin A, 13,14-Seco-16, 24-Cyclo-steroid, inhibits Stemness of breast cancer cells by regulation of hedgehog Signaling pathway and yes-associated protein 1 (YAP1). International Journal of Molecular Sciences, 22, 8718."}, {"Citation": "Koduru, S., Kumar, R., Srinivasan, S., Evers, M. B., & Damodaran, C. (2010). Notch-1 inhibition by Withaferin-A: A therapeutic target against colon carcinogenesis. Molecular Cancer Therapeutics, 9, 202-210."}, {"Citation": "Kuppusamy, P., Nagalingam, A., Muniraj, N., Saxena, N. K., & Sharma, D. (2017). Concomitant activation of ETS-like transcription factor-1 and death Receptor-5 via extracellular signal-regulated kinase in withaferin A-mediated inhibition of hepatocarcinogenesis in mice. Scientific Reports, 7, 17943."}, {"Citation": "Kyakulaga, A. H., Aqil, F., Munagala, R., & Gupta, R. C. (2018). Withaferin A inhibits epithelial to mesenchymal transition in non-small cell lung cancer cells. Scientific Reports, 8, 15737."}, {"Citation": "Lacombe, J., Cretignier, T., Meli, L., Wijeratne, E. M. K., Veuthey, J.-L., Cuendet, M., Gunatilaka, A. A. L., & Zenhausern, F. (2019). Withanolide D enhances Radiosensitivity of human cancer cells by inhibiting DNA damage non-homologous end joining repair pathway. Frontiers in Oncology, 9, 1468."}, {"Citation": "Lai, Y.-H., Chen, W.-N., Hsu, T.-C., Lin, C., Tsao, Y., & Wu, S. (2020). Overall survival prediction of non-small cell lung cancer by integrating microarray and clinical data with deep learning. Scientific Reports, 10, 4679."}, {"Citation": "Lavie, D., Glotter, E., & Shvo, Y. (1965). 1371. Constituents of Withania somnifera dun. Part IV. The structure of withaferin A. J Chem Soc Resumed, 30, 7517-7531. The Royal Society of Chemistry."}, {"Citation": "Lee, C.-C., Chang, W.-H., Chang, Y.-S., Liu, T.-Y., Chen, Y.-C., Wu, Y.-C., & Chang, J.-G. (2017). 4\u03b2-Hydroxywithanolide E modulates alternative splicing of apoptotic genes in human hepatocellular carcinoma Huh-7 cells. Scientific Reports, 7, 7290."}, {"Citation": "Lee, D., Yu, J. S., Ha, J. W., Lee, S. R., Lee, B. S., Kim, J.-C., Kim, J. K., Kang, K. S., & Kim, K. H. (2022). Antitumor potential of Withanolide glycosides from Ashwagandha (Withania somnifera) on apoptosis of human hepatocellular carcinoma cells and tube formation in human umbilical vein endothelial cells. Antioxid Basel Switz, 11, 1761."}, {"Citation": "Lee, J., Hahm, E.-R., & Singh, S. V. (2010). Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells. Carcinogenesis, 31, 1991-1998."}, {"Citation": "Lee, J., Sehrawat, A., & Singh, S. V. (2012). Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells. Breast Cancer Research and Treatment, 136, 45-56."}, {"Citation": "Lee, T.-J., Um, H. J., Min, D. S., Park, J.-W., Choi, K. S., & Kwon, T. K. (2009). Withaferin A sensitizes TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 and down-regulation of c-FLIP. Free Radical Biology & Medicine, 46, 1639-1649."}, {"Citation": "Lei, G., Zhuang, L., & Gan, B. (2022). Targeting ferroptosis as a vulnerability in cancer. Nature Reviews. Cancer, 22, 381-396."}, {"Citation": "Li, G., Peng, X., Guo, Y., Gong, S., Cao, S., & Qiu, F. (2021). Currently available strategies for target identification of bioactive natural products. Frontiers in Chemistry, 9, 761609."}, {"Citation": "Li, L., Niu, B., Zhang, W., Hou, L., & Zheng, Y. (2022). Withaferin A inhibits cell proliferation of U266B1 and IM-9 human myeloma cells by inducing intrinsic apoptosis. Acta Biochim pol, 69, 197-203."}, {"Citation": "Li, W., Zhang, C., Du, H., Huang, V., Sun, B., Harris, J. P., Richardson, Q., Shen, X., Jin, R., Li, G., Kevil, C. G., Gu, X., Shi, R., & Zhao, Y. (2016). Withaferin A SUPPRESSES the up-regulation of acetyl-coA carboxylase 1 and SKIN tumor formation in a skin CARCINOGENESIS mouse model: WITHAFERIN A SUPPRESSES SKIN CARCINOGENESIS. Molecular Carcinogenesis, 55, 1739-1746."}, {"Citation": "Li, W., & Zhao, Y. (2013). Withaferin A suppresses tumor promoter 12 O-tetradecanoylphorbol 13-acetate-induced decreases in isocitrate dehydrogenase 1 activity and mitochondrial function in skin epidermal JB6 cells. Cancer Science, 104, 143-148."}, {"Citation": "Li, X., & Song, Y. (2020). Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy. J Hematol OncolJ Hematol Oncol, 13, 50."}, {"Citation": "Li, X., Zhu, F., Jiang, J., Sun, C., Wang, X., Shen, M., Tian, R., Shi, C., Xu, M., Peng, F., Guo, X., Wang, M., & Qin, R. (2015). Synergistic antitumor activity of withaferin A combined with oxaliplatin triggers reactive oxygen species-mediated inactivation of the PI3K/AKT pathway in human pancreatic cancer cells. Cancer Letters, 357, 219-230."}, {"Citation": "Li, X., Zhu, F., Jiang, J., Sun, C., Zhong, Q., Shen, M., Wang, X., Tian, R., Shi, C., Xu, M., Peng, F., Guo, X., Hu, J., Ye, D., Wang, M., & Qin, R. (2016). Simultaneous inhibition of the ubiquitin-proteasome system and autophagy enhances apoptosis induced by ER stress aggravators in human pancreatic cancer cells. Autophagy, 12, 1521-1537."}, {"Citation": "Liang, J., & Shang, Y. (2013). Estrogen and cancer. Annual Review of Physiology, 75, 225-240."}, {"Citation": "Lin, Y.-H., Hsiao, Y.-H., Ng, K.-L., Kuo, Y.-H., Lim, Y.-P., & Hsieh, W.-T. (2020). Physalin A attenuates inflammation through down-regulating c-Jun NH2 kinase phosphorylation/activator protein 1 activation and up-regulating the antioxidant activity. Toxicology and Applied Pharmacology, 402, 115115."}, {"Citation": "Lippman, M. E., Allegra, J. C., Thompson, E. B., Simon, R., Barlock, A., Green, L., Huff, K. K., Do, H. M. T., Aitken, S. C., & Warren, R. (1978). The relation between Estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. The New England Journal of Medicine, 298, 1223-1228."}, {"Citation": "Liqin, W., Lankhorst, L., & Bernards, R. (2022). Exploiting senescence for the treatment of cancer. Nature Reviews. Cancer, 22, 340-355."}, {"Citation": "Liu, J., Peng, Y., & Wei, W. (2022). Cell cycle on the crossroad of tumorigenesis and cancer therapy. Trends in Cell Biology, 32, 30-44."}, {"Citation": "Liu, W., Barnette, A. R., Andreansky, S., & Landgraf, R. (2016). ERBB2 overexpression establishes ERBB3-dependent hypersensitivity of breast cancer cells to Withaferin A. Molecular Cancer Therapeutics, 15, 2750-2757."}, {"Citation": "Liu, X., Qi, W., Cooke, L. S., Wijeratne, E. M. K., Xu, Y., Marron, M. T., Gunatilaka, A. A. L., & Mahadevan, D. (2011). An Analog of Withaferin A activates the MAPK and glutathione \u201cstress\u201d pathways and inhibits pancreatic cancer cell proliferation. Cancer Investigation, 8, 668-675."}, {"Citation": "LLanos, G. G., Araujo, L. M., Jim\u00e9nez, I. A., Moujir, L. M., & Bazzocchi, I. L. (2012). Withaferin A-related steroids from Withania aristata exhibit potent antiproliferative activity by inducing apoptosis in human tumor cells. European Journal of Medicinal Chemistry, 13, 499-511."}, {"Citation": "Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021). Hepatocellular carcinoma. Nat Rev Dis Primer, 7, 6."}, {"Citation": "Lu, L., Shi, W., Deshmukh, R. R., Long, J., Cheng, X., Ji, W., Zeng, G., Chen, X., Zhang, Y., & Dou, Q. P. (2014). Tumor necrosis factor-\u03b1 sensitizes breast cancer cells to natural products with proteasome-inhibitory activity leading to apoptosis. PLoS One, 9, e113783."}, {"Citation": "Lu, R., Yu, X., Liang, S., Cheng, P., Wang, Z., He, Z., Lv, Z., Wan, J., Mo, H., Zhu, W., & Chen, A. (2021). Physalin A inhibits MAPK and NF-\u03baB signal transduction through integrin \u03b1V\u03b23 and exerts Chondroprotective effect. Frontiers in Pharmacology, 12, 761922."}, {"Citation": "Lv, T.-Z., & Wang, G.-S. (2015). Antiproliferation potential of withaferin A on human osteosarcoma cells via the inhibition of G2/M checkpoint proteins. Experimental and Therapeutic Medicine, 10, 323-329."}, {"Citation": "Ma, T., Fan, B.-Y., Zhang, C., Zhao, H.-J., Han, C., Gao, C.-Y., Luo, J.-G., & Kong, L.-Y. (2016). Metabonomics applied in exploring the antitumour mechanism of physapubenolide on hepatocellular carcinoma cells by targeting glycolysis through the Akt-p53 pathway. Scientific Reports, 6, 29926."}, {"Citation": "Ma, T., Zhang, Y., Zhang, C., Luo, J.-G., & Kong, L.-Y. (2017). Downregulation of TIGAR sensitizes the antitumor effect of physapubenolide through increasing intracellular ROS levels to trigger apoptosis and autophagosome formation in human breast carcinoma cells. Biochem Pharmacol, 143, 90-106."}, {"Citation": "Ma, Y., Han, W., Li, J., Hu, L., & Zhou, Y. (2015). Physalin B not only inhibits the ubiquitin-proteasome pathway but also induces incomplete autophagic response in human colon cancer cells in vitro. Acta Pharmacologica Sinica, 36, 517-527."}, {"Citation": "Mafra, A., Laversanne, M., Gospodarowicz, M., Klinger, P., De Paula, S. N., Pi\u00f1eros, M., Steliarova-Foucher, E., Bray, F., & Znaor, A. (2022). Global patterns of non-Hodgkin lymphoma in 2020. International Journal of Cancer, 151, 1474-1481."}, {"Citation": "Magalh\u00e3es, H. I. F., Torres, M. R., Costa-Lotufo, L. V., De Moraes, M. O., Pessoa, C., Veras, M. L., Pessoa, O. D. L., Silveira, E. R., & Alves, A. P. N. N. (2010). In-vitro and in-vivo antitumour activity of physalins B and D from Physalis angulata. The Journal of Pharmacy and Pharmacology, 58, 235-241."}, {"Citation": "Majumder, S., Crabtree, J. S., Golde, T. E., Minter, L. M., Osborne, B. A., & Miele, L. (2021). Targeting notch in oncology: The path forward. Nature Reviews. Drug Discovery, 20, 125-144."}, {"Citation": "Makol, A., Kaur, H., Sharma, S., Kanthaje, S., Kaur, R., & Chakraborti, A. (2020). Vimentin as a potential therapeutic target in sorafenib resistant HepG2, a HCC model cell line. Clinical and Molecular Hepatology, 26, 45-53."}, {"Citation": "Malik, F., Kumar, A., Bhushan, S., Khan, S., Bhatia, A., Suri, K. A., Qazi, G. N., & Singh, J. (2007). Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis, 12, 2115-2133."}, {"Citation": "Manoharan, S., Panjamurthy, K., Balakrishnan, S., Vasudevan, K., & Vellaichamy, L. (2009). Circadian time-dependent chemopreventive potential of withaferin-A in 7,12-dimethyl-benz[a]anthracene-induced oral carcinogenesis. Pharmacological Reports, 61, 719-726."}, {"Citation": "Marahatha, R., Gyawali, K., Sharma, K., Gyawali, N., Tandan, P., Adhikari, A., Timilsina, G., Bhattarai, S., Lamichhane, G., Acharya, A., Pathak, I., Devkota, H. P., & Parajuli, N. (2021). Pharmacologic activities of phytosteroids in inflammatory diseases: Mechanism of action and therapeutic potentials. Phytotherapy Research, 35, 5103-5124."}, {"Citation": "Marshall, G. M., Bell, J. L., Koach, J., Tan, O., Kim, P., Malyukova, A., Thomas, W., Sekyere, E. O., Liu, T., Cunningham, A. M., Tobias, V., Norris, M. D., Haber, M., Kavallaris, M., & Cheung, B. B. (2010). TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells. Oncogene, 29, 6172-6183."}, {"Citation": "Mart\u00ednez-Reyes, I., & Chandel, N. S. (2021). Cancer metabolism: Looking forward. Nature Reviews. Cancer, 21, 669-680."}, {"Citation": "Massagu\u00e9, J., & Obenauf, A. C. (2016). Metastatic colonization by circulating tumour cells. Nature, 529, 298-306."}, {"Citation": "Matthews, H. K., Bertoli, C., & De Bruin, R. A. M. (2022). Cell cycle control in cancer. Nature Reviews. Molecular Cell Biology, 23, 74-88."}, {"Citation": "Mayola, E., Gallerne, C., Esposti, D. D., Martel, C., Pervaiz, S., Larue, L., Debuire, B., Lemoine, A., Brenner, C., & Lemaire, C. (2011). Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2. Apoptosis, 16, 1014-1027."}, {"Citation": "McKenna, M., Gachuki, B., Alhakeem, S., Oben, K., Rangnekar, V., Gupta, R., & Bondada, S. (2015). Anti-cancer activity of withaferin A in B-cell lymphoma. Cancer Biology & Therapy, 16, 1088-1098."}, {"Citation": "Mittal, V. (2018). Epithelial mesenchymal transition in tumor metastasis. Annu Rev Pathol Mech Dis, 13, 395-412."}, {"Citation": "Mondal, S., Chandan, M., Sangwan, R., Chandra, S., & Chitra, M. (2010). Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. Molecular Cancer, 9, 239."}, {"Citation": "Moustakas, A., & Heldin, C.-H. (2012). Induction of epithelial-mesenchymal transition by transforming growth factor \u03b2. Seminars in Cancer Biology, 22, 446-454."}, {"Citation": "Mu, X., Shi, W., Xu, Y., Xu, C., Zhao, T., Geng, B., Yang, J., Pan, J., Hu, S., Zhang, C., Zhang, J., Wang, C., Shen, J., Che, Y., Liu, Z., Lv, Y., Wen, H., & You, Q. (2018). Tumor-derived lactate induces M2 macrophage polarization via the activation of the ERK/STAT3 signaling pathway in breast cancer. Cell Cycle Georget Tex, 17, 428-438."}, {"Citation": "Munagala, R., Kausar, H., Munjal, C., & Gupta, R. C. (2011). Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells. Carcinogenesis, 32, 1697-1705."}, {"Citation": "Muniraj, N., Siddharth, S., Nagalingam, A., Walker, A., Woo, J., Gyorffy, B., Gabrielson, E., Saxena, N. K., & Sharma, D. (2019). Withaferin A inhibits lysosomal activity to block autophagic flux and induces apoptosis via energetic impairment in breast cancer cells. Carcinogenesis, 40, 1110-1120. https://doi.org/10.1093/carcin/bgz015"}, {"Citation": "Nagalingam, A., Kuppusamy, P., Singh, S. V., Sharma, D., & Saxena, N. K. (2014). Mechanistic elucidation of the antitumor properties of Withaferin A in breast cancer. Cancer Research, 74, 2617-2629."}, {"Citation": "Nagy, Z., Cheung, B. B., Tsang, W., Tan, O., Herath, M., Ciampa, O. C., Shadma, F., Carter, D. R., & Marshall, G. M. (2020). Withaferin A activates TRIM16 for its anti-cancer activity in melanoma. Scientific Reports, 10, 19724."}, {"Citation": "Ndlovu \u2032Matladi, N., Van Lint, C., Van Wesemael, K., Callebert, P., Chalbos, D., Haegeman, G., & Vanden Berghe, W. (2009). Hyperactivated NF-\u03baB and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the Interleukin-6 gene promoter in metastatic breast cancer cells. Molecular and Cellular Biology, 29, 5488-5504."}, {"Citation": "Newman, A. C., & Maddocks, O. D. K. (2017). Serine and functional metabolites in cancer. Trends in Cell Biology, 27, 645-657."}, {"Citation": "Nishi, M., Akutsu, H., Kudoh, A., Kimura, H., Yamamoto, N., Umezawa, A., Lee, S. W., & Ryo, A. (2014). Induced cancer stem-like cells as a model for biological screening and discovery of agents targeting phenotypic traits of cancer stem cell. Oncotarget, 5, 8665-8680."}, {"Citation": "Nishikawa, Y., Okuzaki, D., Fukushima, K., Mukai, S., Ohno, S., Ozaki, Y., Yabuta, N., & Nojima, H. (2015). Withaferin A induces cell death selectively in androgen-independent prostate cancer cells but not in Normal fibroblast cells. PLoS One, 10, e0134137."}, {"Citation": "Nowell, C. S., & Radtke, F. (2017). Notch as a tumour suppressor. Nature Reviews. Cancer, 17, 145-159."}, {"Citation": "Oeckinghaus, A., Hayden, M. S., & Ghosh, S. (2011). Crosstalk in NF-\u03baB signaling pathways. Nature Immunology, 12, 695-708."}, {"Citation": "Oh, J. H., & Kwon, T. K. (2009). Withaferin A inhibits tumor necrosis factor-\u03b1-induced expression of cell adhesion molecules by inactivation of Akt and NF-\u03baB in human pulmonary epithelial cells. International Immunopharmacology, 9, 614-619."}, {"Citation": "Oh, J. H., Lee, T.-J., Kim, S. H., Choi, Y. H., Lee, S. H., Lee, J. M., Kim, Y.-H., Park, J.-W., & Kwon, T. K. (2008). Induction of apoptosis by withaferin A in human leukemia U937 cells through down-regulation of Akt phosphorylation. Apoptosis, 13, 1494-1504."}, {"Citation": "Okamoto, S., Tsujioka, T., Suemori, S., Kida, J., Kondo, T., Tohyama, Y., & Tohyama, K. (2016). Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression. Cancer Science, 107, 1302-1314."}, {"Citation": "Ooi, K. L., Muhammad, T. S. T., & Sulaiman, S. F. (2013). Physalin F from Physalis minima L. triggers apoptosis-based cytotoxic mechanism in T-47D cells through the activation caspase-3- and c-myc-dependent pathways. Journal of Ethnopharmacology, 150, 382-388."}, {"Citation": "Padala, S. A., Adam, B., Thandra, K. C., Saginala, K., Mohammed, A., Vakiti, A., Rawla, P., & Alexander, B. (2020). Epidemiology of renal cell carcinoma. World J Oncol, 11, 79-87."}, {"Citation": "Pan, M.-R., Chang, H.-C., Wu, Y.-C., Huang, C.-C., & Hung, W.-C. (2009). Tubocapsanolide A inhibits transforming growth factor-\u03b2-activating kinase 1 to suppress NF-\u03baB-induced CCR7. The Journal of Biological Chemistry, 284, 2746-2754."}, {"Citation": "Pandey, P., Purohit, D., & Dureja, H. (2018). Nanosponges -A promising novel drug delivery system. Recent Patents on Nanotechnology, 12, 180-191."}, {"Citation": "Panjamurthy, K., Manoharan, S., Nirmal, M. R., & Vellaichamy, L. (2009). Protective role of Withaferin-A on immunoexpression of p53 and bcl-2 in 7,12-dimethylbenz(a)anthracene-induced experimental oral carcinogenesis. Investigational New Drugs, 27, 447-452."}, {"Citation": "Park, E.-J., Sang-Ngern, M., Chang, L. C., & Pezzuto, J. M. (2016). Induction of cell cycle arrest and apoptosis with downregulation of Hsp90 client proteins and histone modification by 4\u03b2-hydroxywithanolide E isolated from Physalis peruviana. Molecular Nutrition & Food Research, 60, 1482-1500."}, {"Citation": "Park, J. W., Min, K.-J., Kim, D. E., & Kwon, T. K. (2015). Withaferin A induces apoptosis through the generation of thiol oxidation in human head and neck cancer cells. International Journal of Molecular Medicine, 35, 247-252."}, {"Citation": "Pavlova, N. N., Zhu, J., & Thompson, C. B. (2022). The hallmarks of cancer metabolism: Still emerging. Cell Metabolism, 34, 355-377."}, {"Citation": "Peng, C. Y., You, B. J., Lee, C. L., Wu, Y. C., Lin, W. H., Lu, T. L., Chang, F.-C., & Lee, H. Z. (2016). The roles of 4\u03b2-Hydroxywithanolide E from Physalis peruviana on the Nrf2-anti-oxidant system and the cell cycle in breast cancer cells. The American Journal of Chinese Medicine, 44, 617-636."}, {"Citation": "Perestelo, N. R., Llanos, G. G., Reyes, C. P., Amesty, A., Sooda, K., Afshinjavid, S., Jim\u00e9nez, I. A., Javid, F., & Bazzocchi, I. L. (2019). Expanding the chemical space of Withaferin A by incorporating silicon to improve its clinical potential on human ovarian carcinoma cells. Journal of Medicinal Chemistry, 62, 4571-4585."}, {"Citation": "Perrotti, D., & Neviani, P. (2013). Protein phosphatase 2A: A target for anticancer therapy. The Lancet Oncology, 14, e229-e238."}, {"Citation": "Peschel, W., Kump, A., & Prieto, J. M. (2011). Effects of 20-hydroxyecdysone, Leuzea carthamoides extracts, dexamethasone and their combinations on the NF- \u03ba B activation in HeLa cells. The Journal of Pharmacy and Pharmacology, 63, 1483-1495."}, {"Citation": "Piao, L., Canguo, Z., Wenjie, L., Xiaoli, C., Wenli, S., & Li, L. (2017). Lipopolysaccharides-stimulated macrophage products enhance Withaferin A-induced apoptosis via activation of caspases and inhibition of NF-\u03baB pathway in human cancer cells. Molecular Immunology, 81, 92-101."}, {"Citation": "Pires, N., Gota, V., Gulia, A., Hingorani, L., Agarwal, M., & Puri, A. (2020). Safety and pharmacokinetics of Withaferin-A in advanced stage high grade osteosarcoma: A phase I trial. J Ayurveda Integr Med, 11, 68-72."}, {"Citation": "Rah, B., Amin, H., Yousuf, K., Khan, S., Jamwal, G., Mukherjee, D., & Goswami, A. (2012). A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4. PLoS One, 7, e44039."}, {"Citation": "Rah, B., ur Rasool, R., Nayak, D., Yousuf, S. K., Mukherjee, D., Kumar, L. D., & Goswami, A. (2015). PAWR-mediated suppression of BCL2 promotes switching of 3-azido withaferin A (3-AWA)-induced autophagy to apoptosis in prostate cancer cells. Autophagy, 11, 314-331."}, {"Citation": "Rao, P. C., Begum, S., Jahromi, M. A. F., Jahromi, Z. H., Sriram, S., & Sahai, M. (2016). Cytotoxicity of withasteroids: Withametelin induces cell cycle arrest at G2/M phase and mitochondria-mediated apoptosis in non-small cell lung cancer A549 cells. Tumor Biology, 37, 12579-12587."}, {"Citation": "Rasool, F., Nayak, D., Katoch, A., Faheem, M. M., Yousuf, S. K., Hussain, N., Belawal, C., Satti, N. K., Goswami, A., & Mukherjee, D. (2017). Regiospecific synthesis of ring A fused Withaferin A Isoxazoline analogues: Induction of premature senescence by W-2b in proliferating cancer cells. Scientific Reports, 7, 13749."}, {"Citation": "Reyes-Reyes, E. M., Jin, Z., Vaisberg, A. J., Hammond, G. B., & Bates, P. J. (2013). Physangulidine A, a withanolide from Physalis angulata, perturbs the cell cycle and induces cell death by apoptosis in prostate cancer cells. Journal of Natural Products, 76, 2-7."}, {"Citation": "Roberts, P. J., & Der, C. J. (2007). Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene, 26, 3291-3310."}, {"Citation": "Rocha, D. D., Balgi, A., Maia, A. I. V., Pessoa, O. D., Silveira, E. R., Costa-Lotufo, L. V., Roberge, M., & Pessoa, C. (2012). Cell cycle arrest through inhibition of tubulin polymerization by withaphysalin F, a bioactive compound isolated from Acnistus arborescens. Investigational New Drugs, 30, 959-966."}, {"Citation": "Romanov, V. S., Pospelov, V. A., & Pospelova, T. V. (2012). Cyclin-dependent kinase inhibitor p21(Waf1): Contemporary view on its role in senescence and oncogenesis. Biochem Biokhimiia, 77, 575-584."}, {"Citation": "Roy, R. V., Suman, S., Das, T. P., Luevano, J. E., & Damodaran, C. (2013). Withaferin A, a steroidal lactone from Withania somnifera, induces mitotic catastrophe and growth arrest in prostate cancer cells. Journal of Natural Products, 76, 1909-1915."}, {"Citation": "Royston, K. J., Paul, B., Nozell, S., Rajbhandari, R., & Tollefsbol TO. (2018). Withaferin A and sulforaphane regulate breast cancer cell cycle progression through epigenetic mechanisms. Experimental Cell Research, 368, 67-74."}, {"Citation": "Samadi, A. K., Bazzill, J., Zhang, X., Gallagher, R., Zhang, H., Gollapudi, R., Kindscher, K., Timmermann, B., & Cohen, M. S. (2012). Novel withanolides target medullary thyroid cancer through inhibition of both RET phosphorylation and the mammalian target of rapamycin pathway. Surgery, 152, 1238-1247."}, {"Citation": "Samadi, A. K., Cohen, S. M., Mukerji, R., Chaguturu, V., Zhang, X., Timmermann, B. N., Cohen, M. S., & Person, E. A. (2012). Natural withanolide withaferin A induces apoptosis in uveal melanoma cells by suppression of Akt and c-MET activation. Tumor Biology, 33, 1179-1189."}, {"Citation": "Samadi, A. K., Mukerji, R., Shah, A., Timmermann, B. N., & Cohen, M. S. (2010). A novel RET inhibitor with potent efficacy against medullary thyroid cancer in vivo. Surgery, 148, 1228-1236."}, {"Citation": "Samadi, A. K., Tong, X., Mukerji, R., Zhang, H., Timmermann, B. N., & Cohen, M. S. (2010). Withaferin A, a Cytotoxic Steroid from Vassobia breviflora, Induces Apoptosis in Human Head and Neck Squamous Cell Carcinoma. Journal of Natural Products, 73, 1476-1481."}, {"Citation": "Samanta, S. K., Lee, J., Hahm, E.-R., & Singh, S. V. (2018). Peptidyl-prolyl cis/trans isomerase Pin1 regulates withaferin A-mediated cell cycle arrest in human breast cancer cells. Molecular Carcinogenesis, 57, 936-946."}, {"Citation": "Samanta, S. K., Sehrawat, A., Kim, S.-H., Hahm, E.-R., Shuai, Y., Roy, R., Pore, S. K., Singh, K. B., Christner, S. M., Beumer, J. H., Davidson, N. E., & Singh, S. V. (2017). Disease subtype-independent biomarkers of breast cancer chemoprevention by the Ayurvedic medicine phytochemical Withaferin A. Journal of the National Cancer Institute, 109, djw293."}, {"Citation": "Sandru, A., Voinea, S., Panaitescu, E., & Blidaru, A. (2014). Survival rates of patients with metastatic malignant melanoma. Journal of Medicine and Life, 7, 572-576."}, {"Citation": "Santagata, S., Xu, Y., Wijeratne, E. M. K., Kontnik, R., Rooney, C., Perley, C. C., Kwon, H., Clardy, J., Kesari, S., Whitesell, L., Lindquist, S., & Gunatilaka, A. A. L. (2012). Using the heat-shock response to discover anticancer compounds that target protein homeostasis. ACS Chemical Biology, 10, 340-349."}, {"Citation": "Sari, A. N., Bhargava, P., Dhanjal, J. K., Putri, J. F., Radhakrishnan, N., Shefrin, S., Ishida, Y., Terao, K., Sundar, D., Kaul, S. C., & Wadhwa, R. (2020). Combination of Withaferin-A and CAPE provides superior anticancer potency: Bioinformatics and experimental evidence to their molecular targets and mechanism of action. Cancers, 12, 1160."}, {"Citation": "Sarkar, S., Chandan, M., Sangwan, R., & Chitra, M. (2014). Coupling G2/M arrest to the Wnt/\u03b2-catenin pathway restrains pancreatic adenocarcinoma. Endocrine-Related Cancer, 21, 113-125."}, {"Citation": "Schmitt, C. A., Wang, B., & Demaria, M. (2022). Senescence and cancer - Role and therapeutic opportunities. Nature Reviews. Clinical Oncology, 19, 619-636."}, {"Citation": "Schwartz, D. M., Bonelli, M., Gadina, M., & O'Shea, J. J. (2016). Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases. Nature Reviews Rheumatology, 12, 25-36."}, {"Citation": "Sehn, L. H., & Salles, G. (2021). Diffuse large B-cell lymphoma. The New England Journal of Medicine, 384, 842-858."}, {"Citation": "Senapati, S., Mahanta, A. K., Kumar, S., & Maiti, P. (2018). Controlled drug delivery vehicles for cancer treatment and their performance. Signal Transduction and Targeted Therapy, 3, 7."}, {"Citation": "Seth, C., Mas, C., Conod, A., Mueller, J., Siems, K., Kuciak, M., Borges, I., & Altaba, A. R. (2016). Long-lasting WNT-TCF response blocking and epigenetic modifying activities of Withanolide F in human cancer cells. PLoS One, 11, e0168170."}, {"Citation": "Shah, H. S., Nasrullah, U., Zaib, S., Usman, F., Khan, A., Gohar, U. F., Uddin, J., Khan, I., & Al-Harrasi, A. (2021). Preparation, characterization, and pharmacological investigation of Withaferin-A loaded Nanosponges for cancer therapy; in vitro, in vivo and molecular docking studies. In Preparation, characterization, and pharmacological investigation of Withaferin-A loaded Nanosponges for cancer therapy; in vitro (p. 26). In Vivo and Molecular Docking Studies."}, {"Citation": "Shah, N., Kataria, H., Kaul, S. C., Ishii, T., Kaur, G., & Wadhwa, R. (2009). Effect of the alcoholic extract of Ashwagandha leaves and its components on proliferation, migration, and differentiation of glioblastoma cells: Combinational approach for enhanced differentiation. Cancer Science, 100, 1740-1747."}, {"Citation": "Shelton, S. E., Nguyen, H. T., Barbie, D. A., & Kamm, R. D. (2021). Engineering approaches for studying immune-tumor cell interactions and immunotherapy. iScience, 24, 101985."}, {"Citation": "Shin, J. M., Lee, K.-M., Lee, H. J., Yun, J. H., & Nho, C. W. (2019). Physalin A regulates the Nrf2 pathway through ERK and p38 for induction of detoxifying enzymes. BMC Complementary and Alternative Medicine, 19, 101."}, {"Citation": "Shohat, B., Gitter, S., Abraham, A., & Lavie, D. (1967). Antitumor activity of withaferin A (NSC-101088). Cancer Chemotherapy Reports, 51, 271-276."}, {"Citation": "Shu, Z., Xing, N., Wang, Q., Li, X., Xu, B., Li, Z., & Kuang, H. (2016). Antibacterial and anti-inflammatory activities of Physalis Alkekengi var. franchetii and its Main constituents. Evidence-Based Complementary and Alternative Medicine, 2016, 1-10."}, {"Citation": "Shuaib, M., Prajapati, K. S., Gupta, S., & Kumar, S. (2022). Natural steroidal lactone induces G1/S phase cell cycle arrest and intrinsic apoptotic pathway by up-regulating tumor suppressive miRNA in triple-negative breast cancer cells. Metabolites, 13, 29."}, {"Citation": "Siddharth, S., Muniraj, N., Saxena, N., & Sharma, D. (2019). Concomitant inhibition of Cytoprotective autophagy augments the efficacy of Withaferin A in hepatocellular carcinoma. Cancers, 11, 453."}, {"Citation": "Siebel, C., & Lendahl, U. (2017). Notch Signaling in development, tissue homeostasis, and disease. Physiological Reviews, 97, 1235-1294."}, {"Citation": "Sinha, P., & Ostrand-Rosenberg, S. (2013). Myeloid-derived suppressor cell function is reduced by Withaferin A, a potent and abundant component of Withania somnifera root extract. Cancer Immunology, Immunotherapy, 62, 1663-1673."}, {"Citation": "Spears, M., & Bartlett, J. (2009). The potential role of estrogen receptors and the SRC family as targets for the treatment of breast cancer. Expert Opinion on Therapeutic Targets, 13, 665-674."}, {"Citation": "Srinivasan, S., Ranga, R. S., Burikhanov, R., Han, S.-S., & Chendil, D. (2007). Par-4-dependent apoptosis by the dietary compound Withaferin A in prostate cancer cells. Cancer Research, 67, 246-253."}, {"Citation": "Stan, S. D., Hahm, E.-R., Warin, R., & Singh, S. V. (2008). Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Research, 68, 7661-7669."}, {"Citation": "Stine, Z. E., Schug, Z. T., Salvino, J. M., & Dang, C. V. (2022). Targeting cancer metabolism in the era of precision oncology. Nature Reviews. Drug Discovery, 21, 141-162."}, {"Citation": "Straughn, A. R., & Kakar, S. S. (2019). Withaferin A ameliorates ovarian cancer-induced cachexia and proinflammatory signaling. J Ovarian Res, 12, 115."}, {"Citation": "Subramanian, C., Grogan, P. T., Opipari, V. P., Timmermann, B. N., & Cohen, M. S. (2018). Novel natural withanolides induce apoptosis and inhibit migration of neuroblastoma cells through down regulation of N-myc and suppression of Akt/mTOR/NF-\u03baB activation. Oncotarget, 9, 14509-14523."}, {"Citation": "Subramanian, C., Zhang, H., Gallagher, R., Hammer, G., Timmermann, B., & Cohen, M. (2014). Withanolides are potent novel targeted therapeutic agents against adrenocortical carcinomas. World Journal of Surgery, 38, 1343-1352."}, {"Citation": "Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71, 209-249."}, {"Citation": "Suttana, W., Mankhetkorn, S., Poompimon, W., Palagani, A., Zhokhov, S., Gerlo, S., Haegeman, G., & Berghe, W. V. (2010). Differential chemosensitization of P-glycoprotein overexpressing K562/Adr cells by withaferin A and Siamois polyphenols. Molecular Cancer, 9, 99."}, {"Citation": "Szarc vel Szic, K., Op de Beeck, K., Ratman, D., Wouters, A., Beck, I. M., Declerck, K., Heyninck, K., Fransen, E., Bracke, M., De Bosscher, K., Lardon, F., Van Camp, G., & Berghe, W. V. (2014). Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells. PLoS One, 9, e87850."}, {"Citation": "Tabassam, Q., Mehmood, T., Raza, A. R., Ullah, A., Saeed, F., & Anjum, F. M. (2020). Synthesis, characterization and anti-cancer therapeutic potential of Withanolide-A with 20nm sAuNPs conjugates against SKBR3 breast cancer cell line. International Journal of Nanomedicine, 15, 6649-6658."}, {"Citation": "Tang, Q., Ren, L., Liu, J., Li, W., Zheng, X., Wang, J., & Du, G. (2020). Withaferin A triggers G2/M arrest and intrinsic apoptosis in glioblastoma cells via ATF4-ATF3-CHOP axis. Cell Proliferation, 53, e12706."}, {"Citation": "Tewary, P., Brooks, A. D., Xu, Y.-M., Wijeratne, E. M. K., Babyak, A. L., Back, T. C., Chari, R., Evans, C. N., Henrich, C. J., Meyer, T. J., Edmondson, E. F., de Aquino, M. T. P., Kanagasabai, T., Shanker, A., Gunatilaka, A. A. L., & Sayers, T. J. (2021). Small-molecule natural product Physachenolide C potentiates immunotherapy efficacy by targeting BET proteins. Cancer Research, 81, 3374-3386."}, {"Citation": "Thaiparambil, J. T., Bender, L., Ganesh, T., Kline, E., Patel, P., Liu, Y., Tighiouart, M., Vertino, P. M., Harvey, R. D., Garcia, A., & Marcus, A. I. (2011). Withaferin A inhibits breast cancer invasion and metastasis at subcytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Cancer Ther, 12, 822."}, {"Citation": "the International Natural Product Sciences Taskforce, Atanasov, A. G., Zotchev, S. B., Dirsch, V. M., & Supuran, C. T. (2021). Natural products in drug discovery: Advances and opportunities. Nature Reviews. Drug Discovery, 20, 200-216."}, {"Citation": "Thiery, J. P. (2002). Epithelial-mesenchymal transitions in tumour progression. Nature Reviews. Cancer, 2, 442-454."}, {"Citation": "Torchilin, V. P. (2005). Recent advances with liposomes as pharmaceutical carriers. Nature Reviews. Drug Discovery, 4, 145-160."}, {"Citation": "Ullah, R., Yin, Q., Snell, A. H., & Wan, L. (2022). RAF-MEK-ERK pathway in cancer evolution and treatment. Seminars in Cancer Biology, 85, 123-154."}, {"Citation": "Um, H. J., Min, K., Kim, D. E., & Kwon, T. K. (2012). Withaferin A inhibits JAK/STAT3 signaling and induces apoptosis of human renal carcinoma Caki cells. Biochemical and Biophysical Research Communications, 427, 24-29."}, {"Citation": "ur Rasool, R., Rah, B., Amin, H., Nayak, D., Chakraborty, S., Rawoof, A., Mintoo, M. J., Yousuf, K., Mukherjee, D., Kumar, L. D., Mondhe, D. M., & Goswami, A. (2016). Dual modulation of Ras-Mnk and PI3K-AKT-mTOR pathways: A novel c-FLIP inhibitory mechanism of 3-AWA mediated translational attenuation through dephosphorylation of eIF4E. Scientific Reports, 6, 18800."}, {"Citation": "van Weelden, W. J., Massuger LFAG, ENITEC, Pijnenborg, J. M. A., & Romano, A. (2019). Anti-estrogen treatment in endometrial cancer: A systematic review. Frontiers in Oncology, 9, 359."}, {"Citation": "Vitale, I., Galluzzi, L., Castedo, M., & Kroemer, G. (2011). Mitotic catastrophe: A mechanism for avoiding genomic instability. Nature Reviews. Molecular Cell Biology, 12, 385-392."}, {"Citation": "Vuoriluoto, K., Haugen, H., Kiviluoto, S., Mpindi, J.-P., Nevo, J., Gjerdrum, C., Tiron, C., Lorens, J. B., & Ivaska, J. (2011). Vimentin regulates EMT induction by slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene, 30, 1436-1448."}, {"Citation": "Wang, H.-C., Hu, H.-H., Chang, F.-R., Tsai, J.-Y., Kuo, C.-Y., Wu, Y.-C., & Wu, C.-C. (2019). Different effects of 4\u03b2-hydroxywithanolide E and withaferin A, two withanolides from Solanaceae plants, on the Akt signaling pathway in human breast cancer cells. Phytomedicine, 53, 213-222."}, {"Citation": "Wang, H.-C., Tsai, Y.-L., Wu, Y.-C., Chang, F.-R., Liu, M.-H., Chen, W.-Y., & Wu, C.-C. (2012). Withanolides-induced breast cancer cell death is correlated with their ability to inhibit heat protein 90. PLoS One, 7, e37764."}, {"Citation": "Wang, H.-Y., Yu, P., Chen, X.-S., Wei, H., Cao, S.-J., Zhang, M., Zhang, Y., Tao, Y.-G., Cao, D.-S., Qiu, F., & Cheng, Y. (2022). Identification of HMGCR as the anticancer target of physapubenolide against melanoma cells by in silico target prediction. Acta Pharmacologica Sinica, 43, 1594-1604."}, {"Citation": "Wang, L., Gu, J., Zong, M., Zhang, Q., Li, H., Li, D., Mou, X., Liu, P., Liu, Y., Qiu, F., & Zhao, F. (2021). Anti-inflammatory action of physalin A by blocking the activation of NF-\u03baB signaling pathway. J Ethnopharmacol, 267, 113490."}, {"Citation": "Wang, L., Lu, B., He, M., Wang, Y., Wang, Z., & Du, L. (2022). Prostate cancer incidence and mortality: Global status and temporal trends in 89 countries from 2000 to 2019. Frontiers in Public Health, 10, 811044."}, {"Citation": "Wang, T., Subramanian, C., Yu, M., White, P. T., Kuai, R., Sanchez, J., Moon, J. J., Timmermann, B. N., Schwendeman, A., & Cohen, M. S. (2019). Mimetic sHDL nanoparticles: A novel drug-delivery strategy to target triple-negative breast cancer. Surgery, 166, 1168-1175."}, {"Citation": "Wang, Y., Shen, Y., Wang, S., Shen, Q., & Zhou, X. (2018). The role of STAT3 in leading the crosstalk between human cancers and the immune system. Cancer Letters, 415, 117-128."}, {"Citation": "Warburg, O., Wind, F., & Negelein, E. (1927). The metabolism of TUMORS in the body. The Journal of General Physiology, 8, 519-530."}, {"Citation": "Wijeratne, E. M. K., Xu, Y.-M., Scherz-Shouval, R., Marron, M. T., Rocha, D. D., Liu, M. X., Costa-Lotufo, L. V., Santagata, S., Lindquist, S., Whitesell, L., & Gunatilaka, A. A. L. (2014). Structure-activity relationships for withanolides as inducers of the cellular heat-shock response. Journal of Medicinal Chemistry, 57, 2851-2863."}, {"Citation": "Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016). Analysis of nanoparticle delivery to tumours. Nature Reviews Materials, 1, 16014."}, {"Citation": "Wu, C., Zheng, M., Gao, S., Luan, S., Cheng, L., Wang, L., Li, J., Chen, L., & Li, H. (2017). A natural inhibitor of kidney-type glutaminase: A withanolide from Physalis pubescens with potent anti-tumor activity. Oncotarget, 8, 113516-113530."}, {"Citation": "Wu, J., Liu, T., Rios, Z., Mei, Q., Lin, X., & Cao, S. (2017). Heat shock proteins and cancer. Trends in Pharmacological Sciences, 38, 226-256."}, {"Citation": "Wu, S.-Y., Leu, Y.-L., Chang, Y.-L., Wu, T.-S., Kuo, P.-C., Liao, Y.-R., Teng, C.-M., & Pan, S.-L. (2012). Physalin F induces cell apoptosis in human renal carcinoma cells by targeting NF-kappaB and generating reactive oxygen species. PLoS One, 7, e40727."}, {"Citation": "Wu, Y., & Zhou, B. P. (2010). TNF-\u03b1/NF-\u03baB/snail pathway in cancer cell migration and invasion. British Journal of Cancer, 102, 639-644."}, {"Citation": "Xia, G.-Y., Cao, S.-J., Chen, L.-X., & Qiu, F. (2022). Natural withanolides, an update. Natural Product Reports, 39, 784-813."}, {"Citation": "Xia, L., Oyang, L., Lin, J., Tan, S., Han, Y., Wu, N., Yi, P., Tang, L., Pan, Q., Rao, S., Liang, J., Tang, Y., Su, M., Luo, X., Yang, Y., Shi, Y., Wang, H., Zhou, Y., & Liao, Q. (2021). The cancer metabolic reprogramming and immune response. Molecular Cancer, 20, 28."}, {"Citation": "Xia, L., Tan, S., Zhou, Y., Lin, J., Heran, W., Oyang, L., Tian, Y., Liu, L., Su, M., Hui, W., Cao, D., & Liao, Q. (2018). Role of the NF&kappa;B-signaling pathway in cancer. OncoTargets and Therapy, 11, 2063-2073."}, {"Citation": "Xia, S., Miao, Y., & Liu, S. (2018). Withaferin A induces apoptosis by ROS-dependent mitochondrial dysfunction in human colorectal cancer cells. Biochem Biophys Res Commun, 503, 2363-2369."}, {"Citation": "Xiang, K., Li, C., Li, M.-X., Song, Z.-R., Ma, X.-X., Sun, D.-J., Li, H., & Chen, L.-X. (2021). Withanolides isolated from Tubocapsicum anomalum and their antiproliferative activity. Bioorganic Chemistry, 110, 104809."}, {"Citation": "Xiang, L., Mou, J., Shao, B., Wei, Y., Liang, H., Takano, N., Semenza, G. L., & Xie, G. (2019). Glutaminase 1 expression in colorectal cancer cells is induced by hypoxia and required for tumor growth, invasion, and metastatic colonization. Cell Death & Disease, 10, 40."}, {"Citation": "Xu, J., Wu, Y., Lu, G., Xie, S., Ma, Z., Chen, Z., Shen, H.-M., & Xia, D. (2017). Importance of ROS-mediated autophagy in determining apoptotic cell death induced by physapubescin B. Redox Biology, 12, 198-207."}, {"Citation": "Xu, K., Shi, H., Du, Y., & Ou, J. (2021). Withaferin A inhibits proliferation of human endometrial cancer cells via transforming growth factor-\u03b2 (TGF-\u03b2) signalling. 3 Biotech, 11, 323."}, {"Citation": "Xu, Y.-M., Liu, M. X., Grunow, N., Wijeratne, E. M. K., Paine-Murrieta, G., Felder, S., Kris, R. M., & Gunatilaka, A. A. L. (2015). Discovery of potent 17\u03b2-Hydroxywithanolides for castration-resistant prostate cancer by high-throughput screening of a natural products library for androgen-induced gene expression inhibitors. Journal of Medicinal Chemistry, 58, 6984-6993."}, {"Citation": "Xue, G., & Hemmings, B. A. (2013). PKB/Akt-dependent regulation of cell motility. JNCI J Natl Cancer Inst, 105, 393-404."}, {"Citation": "Xue, X., & Liang, X.-J. (2012). Overcoming drug efflux-based multidrug resistance in cancer with nanotechnology. Chinese Journal of Cancer, 31, 100-109."}, {"Citation": "Yang, G., Nowsheen, S., Aziz, K., & Georgakilas, A. G. (2013). Toxicity and adverse effects of tamoxifen and other anti-estrogen drugs. Pharmacology & Therapeutics, 139, 392-404."}, {"Citation": "Yang, H., Shi, G., & Dou, Q. P. (2007). The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from \u201cIndian winter cherry\u201d. Molecular Pharmacology, 71, 426-437."}, {"Citation": "Yang, H., Wang, Y., Cheryan, V. T., Wu, W., Cui, C. Q., Polin, L. A., Pass, H. I., Dou, Q. P., Rishi, A. K., & Wali, A. (2012). Withaferin A inhibits the proteasome activity in mesothelioma in vitro and in vivo. PLoS One, 7, e41214."}, {"Citation": "Yang, J., Yan, W., Li, Y., Niu, L., Ye, H., & Chen, L. (2019). The natural compound Withaferin A covalently binds to Cys239 of \u03b2-tubulin to promote tubulin degradation. Mol Pharmacol, 96, 711-719."}, {"Citation": "Yang, K.-Y., Wu, C.-R., Zheng, M.-Z., Tang, R.-T., Li, X.-Z., Chen, L.-X., & Li, H. (2019). Physapubescin I from husk tomato suppresses SW1990 cancer cell growth by targeting kidney-type glutaminase. Bioorganic Chemistry, 92, 103186."}, {"Citation": "Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., & Cui, H. (2020). Targeting cancer stem cell pathways for cancer therapy. Signal Transduction and Targeted Therapy, 5, 8."}, {"Citation": "Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., Brown, L. M., Girotti, A. W., Cornish, V. W., Schreiber, S. L., & Stockwell, B. R. (2014). Regulation of Ferroptotic cancer cell death by GPX4. Cell, 156, 317-331."}, {"Citation": "Yang, Y. (2015). Cancer immunotherapy: Harnessing the immune system to battle cancer. The Journal of Clinical Investigation, 125, 3335-3337."}, {"Citation": "Yang, Y., Xiang, K., Sun, D., Zheng, M., Song, Z., Li, M., Wang, X., Li, H., & Chen, L. (2021). Withanolides from dietary tomatillo suppress HT1080 cancer cell growth by targeting mutant IDH1. Bioorg Med Chem, 36, 116095."}, {"Citation": "Yang, Z., Garcia, A., Xu, S., Powell, D. R., Vertino, P. M., Singh, S., & Marcus, A. I. (2013). Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition. PLoS One, 8, e75069."}, {"Citation": "Yco, L. P., Mocz, G., Opoku-Ansah, J., & Bachmann, A. S. (2014). Withaferin A inhibits STAT3 and induces tumor cell death in Neuroblastoma and multiple myeloma. Biochem Insights, 7, BCI.S18863."}, {"Citation": "Ye, Z.-N., Yuan, F., Liu, J.-Q., Peng, X.-R., An, T., Li, X., Kong, L.-M., Qiu, M.-H., & Li, Y. (2019). Physalis peruviana-derived 4\u03b2-Hydroxywithanolide E, a novel antagonist of Wnt Signaling, Inhibits Colorectal Cancer In Vitro and In Vivo. Molecules, 24, 1146."}, {"Citation": "Yen, C.-Y. (2010). 4\u03b2-Hydroxywithanolide E from Physalis peruviana (golden berry) inhibits growth of human lung cancer cells through DNA damage, apoptosis and G2/M arrest. BMC Cancer, 10, 46."}, {"Citation": "Yi, J., & Luo, J. (2010). SIRT1 and p53, effect on cancer, senescence and beyond. Biochimica et Biophysica Acta, 1804, 1684-1689."}, {"Citation": "Yoneyama, T., Arai, M. A., Sadhu, S. K., Ahmed, F., & Ishibashi, M. (2015). Hedgehog inhibitors from Withania somnifera. Bioorganic & Medicinal Chemistry Letters, 25, 3541-3544."}, {"Citation": "You, B.-J., Wu, Y.-C., Lee, C.-L., & Lee, H.-Z. (2014). Non-homologous end joining pathway is the major route of protection against 4\u03b2-hydroxywithanolide E-induced DNA damage in MCF-7 cells. Food and Chemical Toxicology, 65, 205-212."}, {"Citation": "Yu, F., Yu, C., Li, F., Zuo, Y., Wang, Y., Yao, L., Wu, C., Wang, C., & Ye, L. (2021). Wnt/\u03b2-catenin signaling in cancers and targeted therapies. Signal Transduction and Targeted Therapy, 6, 307."}, {"Citation": "Yu, H., Lin, L., Zhang, Z., Zhang, H., & Hu, H. (2020). Targeting NF-\u03baB pathway for the therapy of diseases: Mechanism and clinical study. Signal Transduction and Targeted Therapy, 5, 209."}, {"Citation": "Yu, H., Pardoll, D., & Jove, R. (2009). STATs in cancer inflammation and immunity: A leading role for STAT3. Nature Reviews. Cancer, 9, 798-809."}, {"Citation": "Yu, J., Zhong, B., Xiao, Q., Du, L., Hou, Y., Sun, H.-S., Lu, J.-J., & Chen, X. (2020). Induction of programmed necrosis: A novel anti-cancer strategy for natural compounds. Pharmacology & Therapeutics, 214, 107593."}, {"Citation": "Yu, L., Wei, J., & Liu, P. (2022). Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer. Seminars in Cancer Biology, 85, 69-94."}, {"Citation": "Yu, P., Zhang, C., Gao, C.-Y., Ma, T., Zhang, H., Zhou, M.-M., Yang, Y.-W., Yang, L., & Kong, L.-Y. (2017). Anti-proliferation of triple-negative breast cancer cells with physagulide P: ROS/JNK signaling pathway induces apoptosis and autophagic cell death. Oncotarget, 8, 64032-64049."}, {"Citation": "Yu, T.-J., Cheng, Y.-B., Lin, L.-C., Tsai, Y.-H., Yao, B.-Y., Tang, J.-Y., Chang, F.-R., Yen, C.-H., Ou-Yang, F., & Chang, H.-W. (2021). Physalis peruviana-derived Physapruin A (PHA) inhibits breast cancer cell proliferation and induces oxidative-stress-mediated apoptosis and DNA damage. Antioxid Basel Switz, 10, 393."}, {"Citation": "Yu, T.-J., Tang, J.-Y., Ou-Yang, F., Wang, Y.-Y., Yuan, S.-S. F., Tseng, K., Lin, L.-C., & Chang, H.-W. (2020). Low concentration of Withaferin a inhibits oxidative stress-mediated migration and invasion in Oral cancer cells. Biomolecules, 10, 777."}, {"Citation": "Yu, T.-J., Yen, C.-Y., Cheng, Y.-B., Yen, C.-H., Jeng, J.-H., Tang, J.-Y., & Chang, H.-W. (2022). Physapruin A enhances DNA damage and inhibits DNA repair to suppress Oral cancer cell proliferation. International Journal of Molecular Sciences, 23, 8839."}, {"Citation": "Yu, Y., Hamza, A., Zhang, T., Gu, M., Zou, P., Newman, B., Li, Y., Gunatilaka, A. A. L., Zhan, C.-G., & Sun, D. (2010). Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochemical Pharmacology, 79, 542-551."}, {"Citation": "Yuan, J., Dong, X., Yap, J., & Hu, J. (2020). The MAPK and AMPK signalings: Interplay and implication in targeted cancer therapy. J Hematol OncolJ Hematol Oncol, 13, 113."}, {"Citation": "Zeng, W., Wang, Q., Chen, L., Huang, L., & Zhao, X. (2017). Anticancer effect of PP31J isolated from Physalis pubescens L. in human cervical carcinoma cells. American Journal of Translational Research, 9, 2466-2472."}, {"Citation": "Zhang, X., Mukerji, R., Samadi, A. K., & Cohen, M. S. (2011). Down-regulation of estrogen receptor-alpha and rearranged during transfection tyrosine kinase is associated with withaferin a-induced apoptosis in MCF-7 breast cancer cells. BMC Complementary and Alternative Medicine, 11, 84."}, {"Citation": "Zhang, X., Samadi, A. K., Roby, K. F., Timmermann, B., & Cohen, M. S. (2012). Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A. Gynecologic Oncology, 7, 606-612."}, {"Citation": "Zhang, Y., Tan, Y., Liu, S., Yin, H., Duan, J., Fan, L., Zhao, X., & Jiang, B. (2023). Implications of Withaferin A for the metastatic potential and drug resistance in hepatocellular carcinoma cells via Nrf2-mediated EMT and ferroptosis. Toxicology Mechanisms and Methods, 33, 47-55."}, {"Citation": "Zhang, Y., & Wang, X. (2020). Targeting the Wnt/\u03b2-catenin signaling pathway in cancer. J Hematol OncolJ Hematol Oncol, 13, 165."}, {"Citation": "Zhang, Y., & Zhang, Z. (2020). The history and advances in cancer immunotherapy: Understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cellular & Molecular Immunology, 17, 807-821."}, {"Citation": "Zhao, J., Zhang, L., Dong, X., Liu, L., Huo, L., & Chen, H. (2018). High expression of Vimentin is associated with progression and a poor outcome in glioblastoma. Appl Immunohistochem Mol Morphol AIMM, 26, 337-344."}, {"Citation": "Zhao, X., Huang, L., Xu, W., Xiaoyan, C., Shen, Y., Zeng, W., & Xiao, C. (2017). Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling. Oncotarget, 8, 70130-70141."}, {"Citation": "Zheng, M., Guo, J., Xu, J., Yang, K., Tang, R., Gu, X., Li, H., & Chen, L. (2019). Ixocarpalactone A from dietary tomatillo inhibits pancreatic cancer growth by targeting PHGDH. Food Funct, 10, 3386-3395."}, {"Citation": "Zheng, Y., Liu, Y., Jin, H., Pan, S., Qian, Y., Huang, C., Zeng, Y., Luo, Q., Zeng, M., & Zhang, Z. (2013). Scavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticles. Theranostics, 3, 477-486."}, {"Citation": "Zhu, D., Chen, C., Liu, X., Wang, S., Zhu, J., Zhang, H., Kong, L., & Luo, J. (2021). Osteosarcoma cell proliferation suppression via SHP-2-mediated inactivation of the JAK/STAT3 pathway by tubocapsenolide A. Journal of Advanced Research, 34, 79-91."}, {"Citation": "Zhu, F., Dai, C., Fu, Y., Loo, J. F. C., Xia, D., Gao, S. P., Ma, Z., & Chen, Z. (2016). Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling. Oncotarget, 7, 9462-9476."}, {"Citation": "Z\u00fa\u00f1iga, R., Concha, G., Cayo, A., Cikutovi\u0107-Molina, R., Arevalo, B., Gonz\u00e1lez, W., Catal\u00e1n, M. A., & Z\u00fa\u00f1iga, L. (2020). Withaferin A suppresses breast cancer cell proliferation by inhibition of the two-pore domain potassium (K2P9) channel TASK-3. Biomed Pharmacother Biomedecine Pharmacother, 129, 110383."}], "Title": "REFERENCES"}], "History": [{"Year": "2023", "Month": "11", "Day": "14"}, {"Year": "2023", "Month": "10", "Day": "11"}, {"Year": "2023", "Month": "11", "Day": "28"}, {"Year": "2024", "Month": "2", "Day": "15", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "1", "Day": "5", "Hour": "0", "Minute": "42"}, {"Year": "2024", "Month": "1", "Day": "4", "Hour": "20", "Minute": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["38176694", "10.1002/ptr.8090"]}}]}